- Exchange: Oslo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Pronova BioPharma ASA (PRON)
| Open: | - | Day's Range: | - | Volume: | 145,014 | Bid: | 9.30 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 7.90 | 52wk Range: | 4.95 - 11.00 | 1-Yr Rtn: | -17.58% | Ask: | 8.50 |
Key Statistics for PRON
| Current P/E Ratio (ttm) | 14.9323 |
|---|---|
| Estimated P/E (12/2012) | 7.8451 |
| Earnings Per Share (NOK) (ttm) | 0.5291 |
| Est. EPS (NOK) (12/2012) | 1.0070 |
| Est. PEG Ratio | - |
| Market Cap (M NOK) | 2,376.58 |
| Shares Outstanding (M) | 300.83 |
| Enterprise Value (M NOK) (ttm) | 3,634.11 |
| Enterprise Value/EBITDA (ttm) | 4.83 |
| Price/Book (mrq) | 1.4173 |
| Price/Sale (ttm) | 1.3995 |
| Dividend Indicated Gross Yield | 5.3763 |
| Next Earnings Announcement | 08/15/2012 |
More PRON Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for PRON
- Operating
- Investing
- Financing (M/NOK)
Company Profile & Key Executives for PRON
Pronova BioPharma AS researches, develops, and manufactures marine originated omega-3 derived pharmaceutical products.
| Gert Wilhelm MuntheChairman | Rikke Tobiasson ReinemoDeputy Chairman |
| Morten JursChief Executive Officer | Synne H RoineChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page